Form 8-K - Current report:
SEC Accession No. 0000950170-24-136408
Filing Date
2024-12-16
Accepted
2024-12-16 09:15:19
Documents
14
Period of Report
2024-12-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K fgen-20241216.htm   iXBRL 8-K 57799
2 EX-99.1 fgen-ex99_1.htm EX-99.1 12938
3 GRAPHIC img3914235_0.jpg GRAPHIC 10772
4 GRAPHIC img3914235_1.jpg GRAPHIC 2347
  Complete submission text file 0000950170-24-136408.txt   240648

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20241216.xsd EX-101.SCH 44485
16 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20241216_htm.xml XML 6206
Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 241550276
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)